Candesartan cilexetil: all 38 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationNCT07547878Phase 4
- Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain InjuryEnrolling by invitationNCT05826912Phase 2
- A Pilot Study of Candesartan as a Treatment for Cocaine DependenceTerminatedNCT01938664Phase 2Results posted
- Impact of Diabetes on Left Ventricular RemodelingCompletedNCT01052272Phase 2/3Results posted
- Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)CompletedNCT00690612Phase 3Results posted
- ARIA (Atacand Renoprotection In NephropAthy Pt.)CompletedNCT00573430Phase 4Results posted
- Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and PlaceboCompletedNCT00434967Phase 3Results posted
- Diabetic Retinopathy Candesartan TrialsCompletedNCT00252733Phase 3Results posted
- Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of AgeCompletedNCT00244621Phase 3Results posted
- Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial HypertensionCompletedNCT05920005Phase 3
- Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19TerminatedNCT05122182Phase 2
- The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting ConditionsCompletedNCT04012307Phase 1
- Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential HypertensionCompletedNCT02944734Phase 2
- The Precision Hypertension Care StudyCompletedNCT02774460Phase 4
- Clinical Trial to Compare the Pharmacokinetics of DP-R208CompletedNCT02707224Phase 1
- Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male SugjectsStatus unknownNCT02609711Phase 1
- A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil MonotherapyCompletedNCT02368652Phase 3
- Relative Bioavailability Study of Candesartan Cilexetil Under Fasting ConditionsCompletedNCT02254447Phase 1
- A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential HypertensionStatus unknownNCT02059616Phase 2
- Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting ConditionsCompletedNCT02006602Phase 1
- Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting ConditionsCompletedNCT02006589Phase 1
- Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mgCompletedNCT01926652Phase 1
- Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine BesylateStatus unknownNCT01845272Phase 1
- Renal Response to Lower Body Negative Pressure in Pre-hypertensive StatesCompletedNCT01734096Phase 4
- Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential HypertensionCompletedNCT01303783Phase 2
- The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential HypertensionCompletedNCT01135212Phase 3
- Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe HypertensionCompletedNCT01012479Phase 4
- Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific MealCompletedNCT00905333Phase 1
- Bioequivalence Study in Healthy SubjectsCompletedNCT00844324Phase 1
- Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart FailureTerminatedNCT00843154Phase 3
- Angiotensin-II Blockade in Mitral RegurgitationCompletedNCT00587470Phase 4
- A Pharmacogenomic Study of Candesartan in Heart FailureCompletedNCT00400582Phase 4
- Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor AutoantibodyStatus unknownNCT00360763Phase 4
- High Doses of Candesartan Cilexetil on the Reduction of ProteinuriaCompletedNCT00242346Phase 3
- TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention TrialCompletedNCT00227318Phase 3
- Prophylactic Treatment of Episodic Cluster HeadacheCompletedNCT00184587Phase 2
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive PatientsStatus unknownNCT00125463Phase 3
- Scandinavian Candesartan Acute Stroke Trial (SCAST)CompletedNCT00120003Phase 3